Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II

Julia Kzhyshkowska; Vishwanath Venketaraman; Galileo Escobedo

doi:10.3389/fimmu.2023.1221642

Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II

Front Immunol. 2023 Jun 1:14:1221642. doi: 10.3389/fimmu.2023.1221642. eCollection 2023.

Authors

Julia Kzhyshkowska^{1

2

3}, Vishwanath Venketaraman⁴, Galileo Escobedo⁵

Affiliations

¹ Institute of Transfusion Medicine and Immunology, Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
² German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany.
³ National Research Tomsk State University, Tomsk, Russia.
⁴ Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, United States.
⁵ Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City, Mexico.

No abstract available

Keywords: COVID-19; SARS-CoV-2; aminoacid; inflammation; macrophage; neurodegeneration; virus.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Humans
Inflammation
SARS-CoV-2

Grants and funding

This work was supported by the Development Program of Tomsk State University Priorities 20-30, and grant no. CB-2016-286209 from the Fondo Sectorial de Investigación para la Educación SEP-CONACYT-México.